A recent drug approval by the Food and Drug Administration (FDA) marks another milestone in the treatment of cancer. The action by FDA expands the growing list of approved uses for the immune checkpoint inhibitor pembrolizumab (Keytruda). In this case, it is now approved to treat some adults or children with advanced cancer, regardless of […]
Read more of this post
No comments:
Post a Comment